Strides Pharma Scien

₹677.7 -10.2 | 1.5%

WEBSITE BSE:532531 NSE : STAR 26 Dec, 16:01

Market Cap ₹6245 Cr.

Stock P/E -42.0

P/B 1.8

Current Price ₹677.7

Book Value ₹ 381.6

Face Value 10

52W High ₹1675.3

Dividend Yield 0.37%

52W Low ₹ 634.1

Edit Ratio

Strides Pharma Scien Research see more...

Overview Inc. Year: 1990Industry: Pharmaceuticals & Drugs

Strides Pharma Science Ltd is an totally India-based pharmaceutical corporation. The Company is targeted on development and manufacture of IP-led niche and pharmaceutical merchandise. It operates through segments: Bio-pharmaceutical and Pharmaceutical. Its geographical segment consists of Africa, Australia, Asia (aside from India), North America, Europe, India, and Others. The Company manufactures a number of niche and pharmaceutical products, which include a number of dosage forms inclusive of, liquids, lotions and ointments, soft gels, sachets, tablets, and modified release dosage codecs. It has eight manufacturing gadgets positioned in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the US (Florida) and Kenya (Nairobi). It is also engaged in production soft gelatin capsules. It develops and manufactures drugs within the anti-retro viral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious ailment drug segments for its institutional commercial enterprise.

Strides Pharma Scien Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Strides Pharma Scien Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Strides Pharma Scien Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Net Sales	1064	929	2222	1382	1470	1537	1692	1858	1979	1854	2153
Other Income	121	100	109	169	156	115	93	117	123	100	80
Total Income	1185	1030	2331	1551	1626	1652	1785	1975	2102	1954	2234
Total Expenditure	915	795	1952	1211	1273	1398	1487	1698	1902	1772	1906
Operating Profit	269	234	379	340	353	254	298	276	200	183	328
Interest	105	34	103	72	82	54	67	65	74	139	168
Depreciation	47	49	103	70	78	83	94	99	104	94	85
Exceptional Income / Expenses	4495	519	-27	-15	-29	-4	0	0	0	-15	-5
Profit Before Tax	4612	669	147	183	164	113	136	112	22	-65	70
Provision for Tax	1099	137	15	31	8	-1	16	33	-159	-69	4
Profit After Tax	3513	532	132	152	156	114	120	78	180	5	65
Adjustments	0	0	-2	-43	735	-4	0	0	0	0	0
Profit After Adjustments	3513	532	130	109	892	110	120	78	180	5	65
Adjusted Earnings Per Share	589.8	89.3	14.8	17	17.5	12.8	13.4	8.7	20.1	0.5	7.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	16%	5%	7%	7%
Operating Profit CAGR	79%	6%	5%	2%
PAT CAGR	1200%	-6%	-11%	-33%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	4%	16%	13%	-3%
ROE Average	2%	2%	3%	27%
ROCE Average	5%	3%	4%	28%

Strides Pharma Scien Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	1631	1474	3158	3233	3162	3257	3159	3248	3407	3455	3561
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	233	164	861	769	2	0	0	148	125	285	197
Other Non-Current Liabilities	132	1200	15	26	-37	-63	-37	160	-16	-12	-7
Total Current Liabilities	1652	630	1245	1434	1101	1389	1455	1591	1841	1797	1995
Total Liabilities	3648	3469	5279	5462	4232	4583	4576	5146	5356	5525	5746
Fixed Assets	381	395	984	1124	498	497	578	577	604	584	545
Other Non-Current Assets	955	1725	1650	1759	2234	2422	2603	2826	2777	2814	2786
Total Current Assets	2313	1349	2646	2579	1462	1664	1394	1744	1975	2126	2416
Total Assets	3648	3469	5279	5462	4232	4583	4576	5146	5356	5525	5746

Strides Pharma Scien Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	18	516	264	819	281	72	70	67	25	12	82
Cash Flow from Operating Activities	-3	207	83	412	66	40	138	283	-283	242	-36
Cash Flow from Investing Activities	3999	305	-1064	-344	447	-166	63	-276	19	-183	-61
Cash Flow from Financing Activities	-3498	-802	1571	-67	-707	123	-204	-49	251	11	108
Net Cash Inflow / Outflow	497	-290	590	0	-194	-3	-3	-42	-13	70	11
Closing Cash & Cash Equivalent	516	226	819	281	72	69	67	25	12	82	93

Strides Pharma Scien Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	589.75	89.29	14.77	16.99	17.48	12.78	13.43	8.72	20.07	0.52	7.13
CEPS(Rs)	597.69	97.55	26.26	24.82	26.17	22.05	23.95	19.8	31.69	10.89	16.34
DPS(Rs)	505	108	4	4.5	2	3	14	2.5	0	1.5	2.5
Book NAV/Share(Rs)	273.77	247.18	352.77	360.5	352.29	362.84	352.04	361.65	379.13	380.46	387.16
Core EBITDA Margin(%)	13.88	14.35	12.14	12.35	13.41	9.04	12.08	8.57	3.87	4.46	11.49
EBIT Margin(%)	440.95	75.39	11.22	18.43	16.75	10.87	12.02	9.53	4.84	3.99	11.03
Pre Tax Margin(%)	431.13	71.7	6.6	13.22	11.17	7.35	8.06	6.01	1.09	-3.49	3.23
PAT Margin (%)	328.39	57.05	5.94	11	10.65	7.44	7.11	4.21	9.1	0.25	3.04
Cash Profit Margin (%)	332.81	62.33	10.56	16.06	15.94	12.84	12.68	9.56	14.38	5.3	6.97
ROA(%)	116.73	14.96	3.02	2.83	3.23	2.6	2.63	1.61	3.43	0.09	1.16
ROE(%)	234.3	34.3	5.7	4.77	4.91	3.57	3.76	2.45	5.42	0.14	1.87
ROCE(%)	229.58	35.32	7.57	5.34	5.72	4.27	5.03	4.35	2.18	1.56	4.77
Receivable days	79.57	103.52	77.91	162.86	122.95	122.49	133.56	145.14	195.32	256.27	238.7
Inventory Days	41.14	57.15	43.92	104.17	84.34	88.19	100.98	113.17	110.86	98.79	81.44
Payable days	71.97	118.17	93.28	240.46	201.2	186.92	204.46	226.09	228.47	220.46	189.28
PER(x)	0.66	13.2	73.71	64.56	38.45	36.92	24.02	96.8	17.27	551.88	109.82
Price/Book(x)	1.41	4.77	3.09	3.04	1.91	1.3	0.92	2.34	0.91	0.75	2.02
Dividend Yield(%)	130.41	9.16	0.37	0.41	0.3	0.64	4.34	0.3	0	0.52	0.32
EV/Net Sales(x)	2.45	7.92	5.03	8.19	4.45	3.16	2.15	4.51	2.19	2.07	4.03
EV/Core EBITDA(x)	9.67	31.43	29.51	33.32	18.52	19.13	12.21	30.33	21.7	21.08	26.48
Net Sales Growth(%)	49.42	-12.64	139.03	-37.8	6.35	4.62	10.05	9.79	6.54	-6.29	16.11
EBIT Growth(%)	3497.83	-85.09	-64.57	2.15	-3.34	-32.09	21.64	-12.94	-45.9	-22.8	221.35
PAT Growth(%)	6174.65	-84.85	-75.22	15.16	2.97	-26.87	5.13	-34.95	130.3	-97.4	1298.78
EPS Growth(%)	6094.37	-84.86	-83.46	15.06	2.88	-26.91	5.11	-35.03	130.02	-97.42	1274.41
Debt/Equity(x)	0.29	0.27	0.49	0.5	0.19	0.25	0.27	0.27	0.37	0.39	0.45
Current Ratio(x)	1.4	2.14	2.13	1.8	1.33	1.2	0.96	1.1	1.07	1.18	1.21
Quick Ratio(x)	1.32	1.9	1.83	1.54	1.08	0.86	0.64	0.66	0.79	0.91	0.98
Interest Cover(x)	44.91	20.44	2.43	3.54	3	3.09	3.04	2.71	1.29	0.53	1.41
Total Debt/Mcap(x)	0.2	0.06	0.16	0.16	0.1	0.19	0.3	0.12	0.4	0.52	0.22

Strides Pharma Scien Shareholding Pattern

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	30.37	31.07	30.89	28.27	28.07	27.78	27.39	25.88	25.86	25.84
FII	21.21	21.38	18.93	18.8	16.67	17.2	19.45	24.57	26.71	30.08
DII	16.62	15.52	18.89	18.34	20.05	19.95	19.41	18.05	18.56	18.25
Public	31.79	32.03	31.28	34.59	35.21	35.06	33.75	31.5	28.87	25.83
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	2.73	2.81	2.79	2.55	2.54	2.51	2.52	2.38	2.38	2.38
FII	1.9	1.93	1.71	1.7	1.51	1.55	1.79	2.26	2.45	2.77
DII	1.49	1.4	1.71	1.66	1.81	1.8	1.78	1.66	1.71	1.68
Public	2.86	2.89	2.82	3.12	3.18	3.17	3.1	2.9	2.65	2.38
Others	0	0	0	0	0	0	0	0	0	0
Total	8.98	9.03	9.03	9.03	9.03	9.03	9.19	9.19	9.19	9.2

Pros

Debtor days have improved from 220.46 to 189.28days.
Company has reduced debt.

Cons

Promoter holding is low: 25.84%.
Company has a low return on equity of 2% over the last 3 years.
The company has delivered a poor profit growth of -10% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Strides Pharma Scien News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Strides Pharma Scien

Add Watchlist

Strides Pharma Scien Research see more...

Overview Inc. Year: 1990Industry: Pharmaceuticals & Drugs

Strides Pharma Scien Share Price

Alert Data

Quarterly Price

Peer Comparison

Strides Pharma Scien Quarterly Results

Strides Pharma Scien Profit & Loss

Growth Rates

Strides Pharma Scien Balance Sheet

Strides Pharma Scien Cash Flow

Strides Pharma Scien Ratios

Strides Pharma Scien Shareholding Pattern

Strides Pharma Scien News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!